Skip to content

Clinical trials

Phase 2 Hypertension trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 2 Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20061
20074
20081
20122
20132
20141
20172
20182
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Ablative Solutions, Inc.1
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Alnylam Pharmaceuticals1
Aphaia Pharma US LLC1
AstraZeneca1
Bayer1
Corcept Therapeutics1
Cytos Biotechnology AG1
KGK Science Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension22
Obesity3
Diabetes Mellitus2
Diabetes Mellitus, Type 22
ACTH Syndrome, Ectopic1
Adrenal Cortex Neoplasms1
Adrenocortical Carcinoma1
Cushing Syndrome1
Diabetic Nephropathies1
Endocrine System Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.